Cite
Engineering Metabolism of Chimeric Antigen Receptor (CAR) Cells for Developing Efficient Immunotherapies.
MLA
Mangal, Joslyn L., et al. “Engineering Metabolism of Chimeric Antigen Receptor (CAR) Cells for Developing Efficient Immunotherapies.” Cancers, vol. 13, no. 5, Mar. 2021, p. 1123. EBSCOhost, https://doi.org/10.3390/cancers13051123.
APA
Mangal, J. L., Handlos, J. L., Esrafili, A., Inamdar, S., Mcmillian, S., Wankhede, M., Gottardi, R., Acharya, A. P., & Golubovskaya, V. (2021). Engineering Metabolism of Chimeric Antigen Receptor (CAR) Cells for Developing Efficient Immunotherapies. Cancers, 13(5), 1123. https://doi.org/10.3390/cancers13051123
Chicago
Mangal, Joslyn L., Jamie L. Handlos, Arezoo Esrafili, Sahil Inamdar, Sidnee Mcmillian, Mamta Wankhede, Riccardo Gottardi, Abhinav P. Acharya, and Vita Golubovskaya. 2021. “Engineering Metabolism of Chimeric Antigen Receptor (CAR) Cells for Developing Efficient Immunotherapies.” Cancers 13 (5): 1123. doi:10.3390/cancers13051123.